
85.67 Delayed Data As of Mar 24 | ![]() Today’s Change | 18.47 Today|||52-Week Range 95.00 | +125.51% Year-to-Date |
The 10 analysts offering 12-month price forecasts for Reata Pharmaceuticals Inc have a median target of 105.00, with a high estimate of 198.00 and a low estimate of 75.00. The median estimate represents a +22.56% increase from the last price of 85.67.
The current consensus among 10 polled investment analysts is to Buy stock in Reata Pharmaceuticals Inc. This rating has held steady since October, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.